For group @b , during the period in which the patients were receiving @ and @ mg doxazosin XL treatments ; the International Prostate Symptom Score changes were @ and @ ( P < @ ) , the Q ( max ) changes were @ and @ mL/s ( P < @ ) , and the QoL changes were @ and @ ( P < @ ) in groups @ and @ , respectively .